Home Infusion Therapy Market Size & Growth Forecast 2027–2036, By Segments (Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Home Infusion Therapy Market size was valued at USD 45 billion in 2026 and is projected to grow at a 7.89% CAGR from 2027 to 2036, surpassing USD 96.17 billion by 2036. The industry revenue for 2027 is estimated at USD 47.99 billion.
Get more details on this report
Request Free Sample ReportHome Infusion Therapy Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 59.43% share, supported by established reimbursement systems, strong provider networks, and widespread adoption of outpatient and at-home infusion care models.
- Asia Pacific is growing at 9.15% CAGR due to expanding home healthcare access, rising chronic disease burden, and increasing acceptance of cost-efficient residential treatment.
Segment Momentum
- Infusion Pumps lead the market because they provide accurate, continuous drug delivery, reliable flow control, and consistent dosing for a wide range of home-based infusion therapies.
- Chemotherapy is growing rapidly as more oncology treatments move into home settings, improving patient convenience and reducing hospital visits while supporting long-term treatment outside traditional care facilities.
Market Expansion Drivers
- Growing preference for home-based chronic disease management increasing infusion therapy adoption.
- Cost advantages over inpatient care accelerating healthcare payer support for home infusion services.
- Expanding elderly population with mobility limitations driving demand for personalized in-home treatments.
Leading Market Participants
- Top players in the home infusion therapy market include Baxter International Inc. (United States), B. Braun SE (Germany), Becton, Dickinson and Company (United States), Fresenius Kabi AG (Germany), ICU Medical, Inc. (United States), Terumo Corporation (Japan), Option Care Health, Inc. (United States), Amedisys, Inc. (United States), McKesson Corporation (United States), Cencora Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 45 billion
- 2027 Estimated Market Size: USD 47.99 billion.
- Projected Market Size: USD 96.17 billion by 2036
- Growth Forecast: 7.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Infusion Pumps (Product) | Anti-infective (Application)
- Emerging Opportunity Segment: Needleless Connectors (Product) | Chemotherapy (Application)
Market Growth Drivers and Industry Trends
Growing preference for home-based chronic disease management increasing infusion therapy adoption
Growing preference for managing chronic conditions outside hospitals is supporting the home infusion therapy market as patients and healthcare providers increasingly consider clinically appropriate treatments that can be administered in residential settings. Home-based infusion can support therapies requiring repeated or extended administration while reducing the need for frequent hospital visits and allowing patients to maintain greater continuity in their daily routines. Improvements in portable infusion equipment, remote clinical oversight, and home healthcare services are also making treatment delivery more practical for selected patients.
Cost advantages over inpatient care accelerating healthcare payer support for home infusion services
Cost considerations are strengthening the home infusion therapy market because administering suitable therapies at home can reduce dependence on resource-intensive inpatient settings. Healthcare payers and providers can benefit from lower facility utilization while patients may avoid expenses and disruptions associated with repeated hospital stays. As healthcare systems place greater emphasis on resource optimization and alternative care pathways, reimbursement support and care models that favor clinically appropriate home treatment can encourage broader use of infusion services outside traditional hospital environments.
Expanding elderly population with mobility limitations driving demand for personalized in-home treatments
An expanding elderly population is increasing demand for the home infusion therapy market, particularly among patients who face mobility challenges or difficulty making frequent visits to healthcare facilities. Home-based treatment allows therapy schedules and administration methods to be adapted to individual patient needs while reducing the physical burden associated with travel and prolonged facility visits. The availability of trained home healthcare professionals, portable infusion devices, and individualized monitoring can further support treatment continuity for older adults requiring ongoing infusion-based care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing preference for home-based chronic disease management increasing infusion therapy adoption | 1.90% | Moderate | North America, Europe | High | Near Term |
| Cost advantages over inpatient care accelerating healthcare payer support for home infusion services | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding elderly population with mobility limitations driving demand for personalized in-home treatments | 1.50% | Moderate | Europe, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the home infusion therapy market, holding a 59.43% share in 2026, supported by well-developed home healthcare infrastructure, established reimbursement mechanisms, and strong acceptance of care delivery outside traditional hospital settings. The region has experienced sustained demand for home-based treatment of chronic conditions, infections, immune disorders, and other conditions requiring extended infusion therapies. Greater emphasis on reducing hospital stays and improving continuity of care has encouraged healthcare providers to shift appropriate patients toward outpatient and home-based treatment models. The availability of trained home healthcare professionals, infusion equipment, specialty pharmacy services, and remote patient monitoring capabilities further strengthens the regional ecosystem. In addition, growing patient preference for convenient treatment environments and healthcare systems focused on managing costs while maintaining clinical outcomes continue to support the adoption of home infusion services.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market as healthcare systems expand their capacity for home-based and decentralized treatment. Rising healthcare expenditure, improving medical infrastructure, and increasing awareness of home healthcare are creating stronger demand for infusion services beyond hospital settings. The growing burden of chronic and long-duration illnesses is also encouraging healthcare providers to explore treatment models that can improve patient convenience while reducing pressure on inpatient facilities. Expansion of private healthcare networks and improvements in nursing and home-care capabilities are helping establish the operational foundation required for infusion therapy at home. Furthermore, increasing adoption of digital health technologies and remote monitoring can support closer coordination between patients and healthcare professionals, strengthening the feasibility of home infusion models across developing healthcare markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Quality IntegrationGermany emphasizes standardized home infusion services supported by clinical protocols and collaboration between hospitals, pharmacies, and home healthcare providers. The country prioritizes treatment continuity while strengthening care pathways for patients with long-term therapeutic needs.
France 🇫🇷
Community Treatment ExpansionFrance continues strengthening home infusion therapy through collaboration between hospital specialists and community healthcare providers. The country places emphasis on improving patient convenience while maintaining clinical oversight for complex infusion treatments delivered at home.
Italy 🇮🇹
Regional Care NetworksItaly is expanding home infusion therapy by improving coordination among regional healthcare systems, hospitals, and community providers. The country focuses on increasing access to home-based treatment while reducing unnecessary hospital admissions for chronic disease management.
Japan 🇯🇵
Aging Care SupportJapan's home infusion therapy market is closely aligned with the needs of its aging population, encouraging broader adoption of home-based treatment for chronic conditions. Healthcare providers continue improving patient education and coordinated nursing services to enhance treatment adherence.
South Korea 🇰🇷
Digital Care CoordinationSouth Korea is integrating home infusion therapy with digital healthcare platforms to improve patient monitoring and treatment management. Healthcare organizations are strengthening remote care capabilities while expanding access to specialized infusion services outside hospital settings.
United States 🇺🇸
Integrated Home Care DeliveryThe U.S. home infusion therapy market is shaped by expanding outpatient care models and coordinated provider networks that support complex treatments outside hospitals. Investment continues to focus on digital patient monitoring, reimbursement optimization, and pharmacy-led care coordination.
Segment Leadership and Growth Trends
Home Infusion Therapy Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Infusion Pumps (Largest Segment) vs Needleless Connectors (Fastest-Growing Segment)
The infusion pumps segment led the home infusion therapy market in 2026, accounting for the largest share. Its strong position is supported by the need for controlled, accurate, and reliable delivery of medications and fluids in home-based care settings. Infusion pumps enable clinicians and patients to administer therapies consistently while reducing the complexity associated with manual infusion methods, making them well suited to long-term and continuous treatment. Their role in improving dosing precision and supporting patient independence continues to reinforce adoption as healthcare systems increasingly shift appropriate therapies from hospitals to home environments.
Needleless connectors are emerging as the fastest-growing product segment, supported by greater emphasis on infection control, patient safety, and ease of use during home-based infusion procedures. These connectors simplify access to infusion lines while reducing repeated needle handling, which can improve convenience for patients and caregivers managing therapies outside clinical facilities. Their compatibility with modern infusion setups and contribution to safer medication administration are further encouraging their integration into home infusion protocols.
Application Segment Analysis: Anti-infective (Largest Segment) vs Chemotherapy (Fastest-Growing Segment)
The anti-infective application segment represented the largest share of the home infusion therapy market in 2026. Its established position reflects the suitability of home-based infusion for administering prolonged courses of intravenous antibiotics and other anti-infective therapies once patients are clinically stable. Home administration can reduce the need for extended hospital stays while allowing treatment to continue under appropriate clinical supervision, supporting greater healthcare efficiency and patient comfort. The growing preference for outpatient and decentralized care is therefore strengthening demand for infusion-based anti-infective treatment.
Chemotherapy is positioned as the fastest-growing application segment as healthcare providers increasingly explore appropriate outpatient and home-centered treatment pathways. Advances in infusion technologies, monitoring capabilities, and supportive care are helping make selected cancer therapies more manageable outside traditional inpatient settings. Greater patient preference for convenient treatment environments, combined with efforts to reduce pressure on hospital infrastructure, is supporting the expansion of home infusion options for chemotherapy where clinically appropriate.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors | Infusion Pumps | Needleless Connectors |
| Application | Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others | Anti-infective | Chemotherapy |
Competitive Landscape and Market Positioning
Major players in the home infusion therapy market:
1. Baxter International Inc. (United States)
2. B. Braun SE (Germany)
3. Becton Dickinson and Company (United States)
4. Fresenius Kabi AG (Germany)
5. ICU Medical Inc. (United States)
6. Terumo Corporation (Japan)
7. Option Care Health Inc. (United States)
8. Amedisys Inc. (United States)
9. McKesson Corporation (United States)
10. Cencora Inc. (United States)
The home infusion therapy market is evolving through improved at-home treatment delivery systems. Innovation is enhancing patient convenience and clinical efficiency. Collaborative healthcare networks are strengthening service accessibility. Continuous development is supporting advanced therapeutic administration methods.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. (United States) | |||||||
| B. Braun SE (Germany) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Fresenius Kabi AG (Germany) | |||||||
| ICU Medical Inc. (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| Option Care Health Inc. (United States) | |||||||
| Amedisys Inc. (United States) | |||||||
| McKesson Corporation (United States) | |||||||
| Cencora Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Soleo Health | Jun-26 | Soleo Health acquired Realo Specialty Care Pharmacy and BluHaven Health, expanding its physical presence in the Mid-Atlantic region and strengthening its specialty pharmacy and home infusion service capabilities. |
| CSI Pharmacy | Jan-26 | CSI Pharmacy established a new regional office in Golden, Colorado, supporting geographic expansion and enhancing regional operational capacity to serve patients requiring specialty infusion therapies. |
| InfuCare Rx | Dec-25 | InfuCare Rx underwent a change in corporate ownership as founder and CEO Deven Patel reacquired the company from One Equity Partners, positioning the business for its next phase of growth in home infusion services. |
| OSAA Innovation | Oct-25 | OSAA Innovation continued the development of connected intravenous therapy technologies designed to improve patient mobility, safety, and convenience, supporting the advancement of technical home-based infusion care solutions. |
| Durham VA Health Care System | Nov-24 | Durham VA Health Care System became the first VA network to provide oncology treatments directly in veterans’ homes, expanding home-based infusion care delivery models and reducing the need for facility-based treatment visits. |
| Performance Home Medical | Oct-24 | Performance Home Medical appointed Larry Mastrovich as Chief Executive Officer to lead the company’s growth initiatives and support expansion across its home-based healthcare services platform. |
| Fresenius Kabi | May-23 | Fresenius Kabi initiated an agreement with Premier, Inc., providing specific pricing and term benefits for the Ivenix Infusion System to advance the reliability and simplicity of infusion pumps. |
| Option Care Health | May-23 | Option Care Health collaborated with Amedisys Inc. to create an independent platform for home care services comprising pharmacists, dieticians, therapists, and social workers to deliver healthcare services at home. |
| ICU Medical | Jan-22 | ICU Medical finalized the acquisition of Smiths Medical from Smiths Group Plc for a combined revenue of USD 2.5 billion, creating a leading specialized infusion therapy company. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Home Infusion Therapy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Care Delivery Model | Self-Administered Therapy, Nurse-Administered Therapy, Caregiver-Assisted Therapy |
| Payer Type | Commercial Insurance, Medicare, Medicaid, Self-Pay |
| Service Provider Type | Home Infusion Providers, Hospital-Based Providers, Specialty Pharmacies, Home Healthcare Agencies |
Home Infusion Therapy Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Home Healthcare Provider Landscape Assessment |
|
| Reimbursement and Payer Coverage Benchmarking |
|
| Home-Based Chronic Care Opportunity Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow large is the home infusion therapy market?
How is the home infusion therapy industry projected to perform over the next decade?
How is the shift toward home-based chronic disease management driving the home infusion therapy market?
Why are healthcare payers increasing support for home infusion therapy services?
Why are Infusion Pumps the largest product segment in the home infusion therapy market?
Why is Chemotherapy the fastest-growing application in the home infusion therapy market?
Why does North America lead the home infusion therapy market?
What is driving growth in Asia Pacific home infusion therapy market?
Who holds a significant market share in the home infusion therapy landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization